A recent study found that a vaginal self-collected human papillomavirus (HPV) test demonstrated high sensitivity for detecting high-grade cervical dysplasia, matching results from clinician-collected samples in a large U.S. trial. This method offers a safe and preferred approach for at-home cervical cancer screening, supporting improved accessibility and uptake among underscreened populations.

Source: JAMA Network Open